CTOs on the Move


 
Foria is an innovative health & sexual wellness company, rooted in the proven wisdom of plants and powered by compassion. Our all natural Cannabis & Hemp formulas have been changing lives since 2014. As the first brand to create comprehensive product lines for intimacy, relief, and optimal wellbeing for women and people with vulvas, it is our joy and mission to offer effective products for important and under-served life experiences. With an unwavering commitment to clean ingredients, organic & regenerative farming, sex education, and responsible packaging, we maintain the highest standards of purity and transparency — for your health, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

meddev-corp

meddev-corp is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FORME

At Forme, we specialize in designing and manufacturing innovative and high-quality health and wellness products. Our extensive range includes sports nutrition, weight loss supplements, and vitamins to support overall wellbeing. We are dedicated to prov...

Fisher Micro

Fisher Micro is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Behavioral Health Services

Since 1973, Behavioral Health Services, Inc. has prided itself on providing a continuum of substance abuse treatment services. Each of our programs is based on the philosophy that recovery from addiction is a life-long process.